These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25272198)

  • 1. Chitosan nanoparticles for siRNA delivery: optimization of processing/formulation parameters.
    Esmaeilzadeh Gharehdaghi E; Amani A; Khoshayand MR; Banan M; Esmaeilzadeh Gharehdaghi E; Amini MA; Faramarzi MA
    Nucleic Acid Ther; 2014 Dec; 24(6):420-7. PubMed ID: 25272198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: an Artificial Neural Networks Study.
    Esmaeilzadeh-Gharedaghi E; Faramarzi MA; Amini MA; Rouholamini Najafabadi A; Rezayat SM; Amani A
    Pharm Dev Technol; 2012; 17(5):638-47. PubMed ID: 22681416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with Ultrasonication Reduces the Size of Azelaic Acid-Chitosan Nanoparticles Prepared by Electrospray.
    Hanafi A; Kamali M; Darvishi MH; Amani A
    Arch Razi Inst; 2018 Dec; 73(1):53-59. PubMed ID: 30256039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
    Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
    Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Self-Assembled Chitosan/Streptokinase Nanoparticles and Evaluation of Their Cytotoxicity and Thrombolytic Activity.
    Baharifar H; Tavoosidana G; Karimi R; Bidgoli SA; Ghanbari H; Faramarzi MA; Amani A
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10127-33. PubMed ID: 26682458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cavitation effect on chitosan nanoparticle size: a possible approach to protect drugs from ultrasonic stress.
    Floris A; Meloni MC; Lai F; Marongiu F; Maccioni AM; Sinico C
    Carbohydr Polym; 2013 Apr; 94(1):619-25. PubMed ID: 23544582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle.
    Iranpur Mobarakeh V; Modarressi MH; Rahimi P; Bolhassani A; Arefian E; Atyabi F; Vahabpour R
    Int J Biol Macromol; 2019 May; 129():305-315. PubMed ID: 30738164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
    Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
    Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.
    Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A
    Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonication of chitosan and chitosan nanoparticles.
    Tang ES; Huang M; Lim LY
    Int J Pharm; 2003 Oct; 265(1-2):103-14. PubMed ID: 14522123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA
    Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
    Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.